 | • レポートコード：QFJ1-4459 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科療法、放射線療法、化学療法、生物学的療法/標的療法）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・悪性黒色腫治療の市場動向 ・企業の競争状況、市場シェア ・悪性黒色腫治療の種類別市場規模と予測2016-2027（外科療法、放射線療法、化学療法、生物学的療法/標的療法） ・悪性黒色腫治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他） ・悪性黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・悪性黒色腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・悪性黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・悪性黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・悪性黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Enzon Pharmaceuticals、Exelixis、GSK、Merck、Pfizer、Roche、Navidea Biopharmaceuticals、Novartis、Ono Pharmaceutical、Amgen、Avax Technologies、Clinigen Group、Pierre Fabre Group、Aptose Biosciences、Daiichi Sankyo、Sanofi、Takeda Pharmaceutical、Qiagen、AstraZeneca、Biogen） ・結論 |
Market Analysis and Insights: Global Malignant Melanoma Treatment Market
The global Malignant Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Malignant Melanoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Malignant Melanoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Malignant Melanoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Malignant Melanoma Treatment market.
Global Malignant Melanoma Treatment Scope and Market Size
Malignant Melanoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Malignant Melanoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical Therapy
Radiation Therapy
Chemotherapy
Biological Therapy/Targeted Therapy
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Enzon Pharmaceuticals
Exelixis
GSK
Merck
Pfizer
Roche
Navidea Biopharmaceuticals
Novartis
Ono Pharmaceutical
Amgen
Avax Technologies
Clinigen Group
Pierre Fabre Group
Aptose Biosciences
Daiichi Sankyo
Sanofi
Takeda Pharmaceutical
Qiagen
AstraZeneca
Biogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malignant Melanoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Therapy
1.2.3 Radiation Therapy
1.2.4 Chemotherapy
1.2.5 Biological Therapy/Targeted Therapy
1.3 Market by Application
1.3.1 Global Malignant Melanoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Malignant Melanoma Treatment Market Perspective (2016-2027)
2.2 Malignant Melanoma Treatment Growth Trends by Regions
2.2.1 Malignant Melanoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Malignant Melanoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Malignant Melanoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Malignant Melanoma Treatment Industry Dynamic
2.3.1 Malignant Melanoma Treatment Market Trends
2.3.2 Malignant Melanoma Treatment Market Drivers
2.3.3 Malignant Melanoma Treatment Market Challenges
2.3.4 Malignant Melanoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malignant Melanoma Treatment Players by Revenue
3.1.1 Global Top Malignant Melanoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Malignant Melanoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Malignant Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Malignant Melanoma Treatment Revenue
3.4 Global Malignant Melanoma Treatment Market Concentration Ratio
3.4.1 Global Malignant Melanoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malignant Melanoma Treatment Revenue in 2020
3.5 Malignant Melanoma Treatment Key Players Head office and Area Served
3.6 Key Players Malignant Melanoma Treatment Product Solution and Service
3.7 Date of Enter into Malignant Melanoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Malignant Melanoma Treatment Breakdown Data by Type
4.1 Global Malignant Melanoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Malignant Melanoma Treatment Forecasted Market Size by Type (2022-2027)
5 Malignant Melanoma Treatment Breakdown Data by Application
5.1 Global Malignant Melanoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Malignant Melanoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Malignant Melanoma Treatment Market Size (2016-2027)
6.2 North America Malignant Melanoma Treatment Market Size by Type
6.2.1 North America Malignant Melanoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Malignant Melanoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Malignant Melanoma Treatment Market Size by Type (2016-2027)
6.3 North America Malignant Melanoma Treatment Market Size by Application
6.3.1 North America Malignant Melanoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Malignant Melanoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Malignant Melanoma Treatment Market Size by Application (2016-2027)
6.4 North America Malignant Melanoma Treatment Market Size by Country
6.4.1 North America Malignant Melanoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Malignant Melanoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Malignant Melanoma Treatment Market Size (2016-2027)
7.2 Europe Malignant Melanoma Treatment Market Size by Type
7.2.1 Europe Malignant Melanoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Malignant Melanoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Malignant Melanoma Treatment Market Size by Type (2016-2027)
7.3 Europe Malignant Melanoma Treatment Market Size by Application
7.3.1 Europe Malignant Melanoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Malignant Melanoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Malignant Melanoma Treatment Market Size by Application (2016-2027)
7.4 Europe Malignant Melanoma Treatment Market Size by Country
7.4.1 Europe Malignant Melanoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Malignant Melanoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Malignant Melanoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Type
8.2.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Malignant Melanoma Treatment Market Size by Application
8.3.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Malignant Melanoma Treatment Market Size by Region
8.4.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Malignant Melanoma Treatment Market Size (2016-2027)
9.2 Latin America Malignant Melanoma Treatment Market Size by Type
9.2.1 Latin America Malignant Melanoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Malignant Melanoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Malignant Melanoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Malignant Melanoma Treatment Market Size by Application
9.3.1 Latin America Malignant Melanoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Malignant Melanoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Malignant Melanoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Malignant Melanoma Treatment Market Size by Country
9.4.1 Latin America Malignant Melanoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Malignant Melanoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malignant Melanoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Type
10.2.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Malignant Melanoma Treatment Market Size by Application
10.3.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Malignant Melanoma Treatment Market Size by Country
10.4.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Malignant Melanoma Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Enzon Pharmaceuticals
11.2.1 Enzon Pharmaceuticals Company Details
11.2.2 Enzon Pharmaceuticals Business Overview
11.2.3 Enzon Pharmaceuticals Malignant Melanoma Treatment Introduction
11.2.4 Enzon Pharmaceuticals Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.2.5 Enzon Pharmaceuticals Recent Development
11.3 Exelixis
11.3.1 Exelixis Company Details
11.3.2 Exelixis Business Overview
11.3.3 Exelixis Malignant Melanoma Treatment Introduction
11.3.4 Exelixis Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.3.5 Exelixis Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Malignant Melanoma Treatment Introduction
11.4.4 GSK Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Malignant Melanoma Treatment Introduction
11.5.4 Merck Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Malignant Melanoma Treatment Introduction
11.6.4 Pfizer Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Malignant Melanoma Treatment Introduction
11.7.4 Roche Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Navidea Biopharmaceuticals
11.8.1 Navidea Biopharmaceuticals Company Details
11.8.2 Navidea Biopharmaceuticals Business Overview
11.8.3 Navidea Biopharmaceuticals Malignant Melanoma Treatment Introduction
11.8.4 Navidea Biopharmaceuticals Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.8.5 Navidea Biopharmaceuticals Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Malignant Melanoma Treatment Introduction
11.9.4 Novartis Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Ono Pharmaceutical
11.10.1 Ono Pharmaceutical Company Details
11.10.2 Ono Pharmaceutical Business Overview
11.10.3 Ono Pharmaceutical Malignant Melanoma Treatment Introduction
11.10.4 Ono Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.10.5 Ono Pharmaceutical Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Malignant Melanoma Treatment Introduction
11.11.4 Amgen Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.11.5 Amgen Recent Development
11.12 Avax Technologies
11.12.1 Avax Technologies Company Details
11.12.2 Avax Technologies Business Overview
11.12.3 Avax Technologies Malignant Melanoma Treatment Introduction
11.12.4 Avax Technologies Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.12.5 Avax Technologies Recent Development
11.13 Clinigen Group
11.13.1 Clinigen Group Company Details
11.13.2 Clinigen Group Business Overview
11.13.3 Clinigen Group Malignant Melanoma Treatment Introduction
11.13.4 Clinigen Group Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.13.5 Clinigen Group Recent Development
11.14 Pierre Fabre Group
11.14.1 Pierre Fabre Group Company Details
11.14.2 Pierre Fabre Group Business Overview
11.14.3 Pierre Fabre Group Malignant Melanoma Treatment Introduction
11.14.4 Pierre Fabre Group Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.14.5 Pierre Fabre Group Recent Development
11.15 Aptose Biosciences
11.15.1 Aptose Biosciences Company Details
11.15.2 Aptose Biosciences Business Overview
11.15.3 Aptose Biosciences Malignant Melanoma Treatment Introduction
11.15.4 Aptose Biosciences Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.15.5 Aptose Biosciences Recent Development
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Details
11.16.2 Daiichi Sankyo Business Overview
11.16.3 Daiichi Sankyo Malignant Melanoma Treatment Introduction
11.16.4 Daiichi Sankyo Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.16.5 Daiichi Sankyo Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Malignant Melanoma Treatment Introduction
11.17.4 Sanofi Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.17.5 Sanofi Recent Development
11.18 Takeda Pharmaceutical
11.18.1 Takeda Pharmaceutical Company Details
11.18.2 Takeda Pharmaceutical Business Overview
11.18.3 Takeda Pharmaceutical Malignant Melanoma Treatment Introduction
11.18.4 Takeda Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.18.5 Takeda Pharmaceutical Recent Development
11.18 Qiagen
.1 Qiagen Company Details
.2 Qiagen Business Overview
.3 Qiagen Malignant Melanoma Treatment Introduction
.4 Qiagen Revenue in Malignant Melanoma Treatment Business (2016-2021)
.5 Qiagen Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Details
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Malignant Melanoma Treatment Introduction
11.20.4 AstraZeneca Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.20.5 AstraZeneca Recent Development
11.21 Biogen
11.21.1 Biogen Company Details
11.21.2 Biogen Business Overview
11.21.3 Biogen Malignant Melanoma Treatment Introduction
11.21.4 Biogen Revenue in Malignant Melanoma Treatment Business (2016-2021)
11.21.5 Biogen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Malignant Melanoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Biological Therapy/Targeted Therapy
Table 6. Global Malignant Melanoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Malignant Melanoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Malignant Melanoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Malignant Melanoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Malignant Melanoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Malignant Melanoma Treatment Market Share by Regions (2022-2027)
Table 12. Malignant Melanoma Treatment Market Trends
Table 13. Malignant Melanoma Treatment Market Drivers
Table 14. Malignant Melanoma Treatment Market Challenges
Table 15. Malignant Melanoma Treatment Market Restraints
Table 16. Global Malignant Melanoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Malignant Melanoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Malignant Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malignant Melanoma Treatment as of 2020)
Table 19. Ranking of Global Top Malignant Melanoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Malignant Melanoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Malignant Melanoma Treatment Product Solution and Service
Table 23. Date of Enter into Malignant Melanoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Malignant Melanoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Malignant Melanoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Malignant Melanoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Malignant Melanoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Malignant Melanoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Malignant Melanoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Malignant Melanoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Malignant Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Malignant Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Malignant Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Malignant Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Malignant Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Malignant Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Malignant Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Malignant Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Malignant Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Malignant Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Malignant Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Malignant Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Malignant Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Malignant Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Malignant Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Malignant Melanoma Treatment Product
Table 66. Bristol-Myers Squibb Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Enzon Pharmaceuticals Company Details
Table 69. Enzon Pharmaceuticals Business Overview
Table 70. Enzon Pharmaceuticals Malignant Melanoma Treatment Product
Table 71. Enzon Pharmaceuticals Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Enzon Pharmaceuticals Recent Development
Table 73. Exelixis Company Details
Table 74. Exelixis Business Overview
Table 75. Exelixis Malignant Melanoma Treatment Product
Table 76. Exelixis Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Exelixis Recent Development
Table 78. GSK Company Details
Table 79. GSK Business Overview
Table 80. GSK Malignant Melanoma Treatment Product
Table 81. GSK Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 82. GSK Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Malignant Melanoma Treatment Product
Table 86. Merck Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Malignant Melanoma Treatment Product
Table 91. Pfizer Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Malignant Melanoma Treatment Product
Table 96. Roche Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Navidea Biopharmaceuticals Company Details
Table 99. Navidea Biopharmaceuticals Business Overview
Table 100. Navidea Biopharmaceuticals Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 101. Navidea Biopharmaceuticals Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Malignant Melanoma Treatment Product
Table 105. Novartis Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Novartis Recent Development
Table 107. Ono Pharmaceutical Company Details
Table 108. Ono Pharmaceutical Business Overview
Table 109. Ono Pharmaceutical Malignant Melanoma Treatment Product
Table 110. Ono Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 111. Ono Pharmaceutical Recent Development
Table 112. Amgen Company Details
Table 113. Amgen Business Overview
Table 114. Amgen Malignant Melanoma Treatment Product
Table 115. Amgen Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Amgen Recent Development
Table 117. Avax Technologies Company Details
Table 118. Avax Technologies Business Overview
Table 119. Avax Technologies Malignant Melanoma Treatment Product
Table 120. Avax Technologies Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 121. Avax Technologies Recent Development
Table 122. Clinigen Group Company Details
Table 123. Clinigen Group Business Overview
Table 124. Clinigen Group Malignant Melanoma Treatment Product
Table 125. Clinigen Group Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 126. Clinigen Group Recent Development
Table 127. Pierre Fabre Group Company Details
Table 128. Pierre Fabre Group Business Overview
Table 129. Pierre Fabre Group Malignant Melanoma Treatment Product
Table 130. Pierre Fabre Group Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 131. Pierre Fabre Group Recent Development
Table 132. Aptose Biosciences Company Details
Table 133. Aptose Biosciences Business Overview
Table 134. Aptose Biosciences Malignant Melanoma Treatment Product
Table 135. Aptose Biosciences Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 136. Aptose Biosciences Recent Development
Table 137. Daiichi Sankyo Company Details
Table 138. Daiichi Sankyo Business Overview
Table 139. Daiichi Sankyo Malignant Melanoma Treatment Product
Table 140. Daiichi Sankyo Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 141. Daiichi Sankyo Recent Development
Table 142. Sanofi Company Details
Table 143. Sanofi Business Overview
Table 144. Sanofi Malignant Melanoma Treatment Product
Table 145. Sanofi Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 146. Sanofi Recent Development
Table 147. Takeda Pharmaceutical Company Details
Table 148. Takeda Pharmaceutical Business Overview
Table 149. Takeda Pharmaceutical Malignant Melanoma Treatment Product
Table 150. Takeda Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 151. Takeda Pharmaceutical Recent Development
Table 152. Qiagen Company Details
Table 153. Qiagen Business Overview
Table 154. Qiagen Malignant Melanoma Treatment Product
Table 155. Qiagen Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 156. Qiagen Recent Development
Table 157. AstraZeneca Company Details
Table 158. AstraZeneca Business Overview
Table 159. AstraZeneca Malignant Melanoma Treatment Product
Table 160. AstraZeneca Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 161. AstraZeneca Recent Development
Table 162. Biogen Company Details
Table 163. Biogen Business Overview
Table 164. Biogen Malignant Melanoma Treatment Product
Table 165. Biogen Revenue in Malignant Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 166. Biogen Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malignant Melanoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical Therapy Features
Figure 3. Radiation Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Biological Therapy/Targeted Therapy Features
Figure 6. Global Malignant Melanoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Malignant Melanoma Treatment Report Years Considered
Figure 12. Global Malignant Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Malignant Melanoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Malignant Melanoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Malignant Melanoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Malignant Melanoma Treatment Market Share by Players in 2020
Figure 17. Global Top Malignant Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malignant Melanoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Malignant Melanoma Treatment Revenue in 2020
Figure 19. Global Malignant Melanoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Malignant Melanoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Malignant Melanoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Malignant Melanoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Malignant Melanoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Malignant Melanoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Malignant Melanoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Malignant Melanoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Malignant Melanoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Malignant Melanoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Malignant Melanoma Treatment Market Share by Region (2016-2027)
Figure 41. China Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Malignant Melanoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Malignant Melanoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Malignant Melanoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Malignant Melanoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Malignant Melanoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Malignant Melanoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Malignant Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 61. Enzon Pharmaceuticals Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 62. Exelixis Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 67. Navidea Biopharmaceuticals Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 69. Ono Pharmaceutical Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 70. Amgen Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 71. Avax Technologies Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 72. Clinigen Group Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 73. Pierre Fabre Group Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 74. Aptose Biosciences Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 75. Daiichi Sankyo Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 76. Sanofi Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 77. Takeda Pharmaceutical Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 78. Qiagen Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 79. AstraZeneca Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 80. Biogen Revenue Growth Rate in Malignant Melanoma Treatment Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の転移性悪性黒色腫治療市場規模・現状・予測（2021年-2027年） Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Melanoma Treatment Market The global Metastatic Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…